|
1.精神分裂症是一个重要的公共卫生问题。
2.尽管精神分裂症成为一个独立的疾病实体称谓己有百年历史，但它的定义、内涵一直随着时代发展和认识的深化而不断变化、发展。
3.精神分裂症作为一种最常见的重性精神疾病，其病因病理生理机制仍然不明确，新型抗精神病药物显著改善了精分裂症的预后。要强调精神分裂症的早期诊断、早期干预和全病程管理，强调精神分裂症的整合治疗(药物治疗和非药物治疗的结合)，特别强调社区综合治疗的重要性。（徐一峰）
参考文献
1.徐韬园.我国现代精神病学发展史[J]中华神经精神科杂志，1995,28（6）：168-176
2.冉茂盛，向孟泽.农村社区精神分裂症及情感性精神病人治疗依从性
的研究[J].华西医学，1993, 8 (1): 2-5.
3.张维熙，李淑然.陈昌惠，等.中国七个地区精神疾病流行病学调查[J].
中华精神科杂志，1998, 31 (2): 69-70.
4. Lecrubier Y, Perry R, M一川gan G, et al. Physician observations and
perceptions of positive and negative symptoms of schizophrenia: A
multinational, cross-sectional survey[J]. European Psychiatry, 2007, 22
(6):371-379.
5. Lee KU, Jeon YW, Lee HK, et al. Efficacy for depressive symptoms
Psychopharmacol Clin Exp,in patients with and safety of quetiapine
schiiophrenia[J]. Hum
2009,24:447一52.
6. Kasper S. Optimisation of long-term treatment in schizophrenia:
Treating
the true spectrum of symptoms[习European Neuropsychopharmacology,
2006, 16: S135-S141.
7. Dutta R, Murray RM, Hotopf M, et al. Reassessing the long-term risk
of
suicide after a first episode of psychosis[J]. Arch Gen Psychiatry,
2010,
67 (12): 1230-1237.
8. Kane JM. Treatment strategies to prevent relapse and encourage
remission[J]. J Clin Psychiatry, 2007, 68 (suppl.l4): 27-30.
9. Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of
schizophrenia in the United States in 2002[J]. J Clin Psychiatry, 2005,
66
(9): 1122-1129.
10. Meltzcr HY.llluminating the molecular basis for some antipsychotic
drug-
induced metabolic burden[月.Proceedings of the National Academy of
Sciences of the United States of America, 2007, 104 (9): 3019-3020.
11. Phillips MR. Zhang J. Shi Q, et al. Prevalence, treatment, and
associated
disability of mental disorders in four provinces in China during
2001-05:
an epidemiological survey[J]. Lancet, 2009, 373 (9680): 2041-20勿.
|
